Douglas C. Kovacs

FDA investigator

Appears on 3 documents from 2006 to 2013, mostly at sites in New Jersey. Most often cites control of microbiological contamination (21 CFR 211.113(b)).

3
Documents on file
5.0
Observations per 483
2006
First seen
2013
Most recent

What they cite most

From 5 observations

Activity by year

2006: 1, 2013: 2

Where

New Jersey 3

Often inspects with

Michael R. Klapal

Is Douglas C. Kovacs coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

3 documents, newest first
FirmOpen
Response Pharmacy Creations, LLCSep 3, 2013 · Randolph, New Jersey
483 Pharmacy CreationsAug 19, 2013 · Randolph, New Jersey
EIR Actavis Totowa, LLCNov 30, 2006 · Totowa, New Jersey

About this profile

What does Douglas C. Kovacs inspect?

Douglas C. Kovacs appears on 3 documents on file covering 2 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 211.113(b) (control of microbiological contamination), followed by 21 CFR 211.166(b) and 21 CFR 211.167(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Douglas C. Kovacs is dated Sep 3, 2013.